Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status

SARS-CoV-2 is causing an increasing number of deaths worldwide because no effective treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses and is a possible antiviral treatment for SARS-CoV-2 infection. This prospective (compassionate), open-label study of rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Antinori, Spinello, Cossu, Maria Vittoria, Ridolfo, Anna Lisa, Rech, Roberto, Bonazzetti, Cecilia, Pagani, Gabriele, Gubertini, Guido, Coen, Massimo, Magni, Carlo, Castelli, Antonio, Borghi, Beatrice, Colombo, Riccardo, Giorgi, Riccardo, Angeli, Elena, Mileto, Davide, Milazzo, Laura, Vimercati, Stefania, Pellicciotta, Martina, Corbellino, Mario, Torre, Alessandro, Rusconi, Stefano, Oreni, Letizia, Gismondo, Maria Rita, Giacomelli, Andrea, Meroni, Luca, Rizzardini, Giuliano, Galli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212963/
https://www.ncbi.nlm.nih.gov/pubmed/32407959
http://dx.doi.org/10.1016/j.phrs.2020.104899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212963/
https://www.ncbi.nlm.nih.gov/pubmed/32407959
http://dx.doi.org/10.1016/j.phrs.2020.104899

Ejemplares similares